300 patients tracked after eye disease treatments – what really happens?
NCT ID NCT07216677
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 300 patients with chronic eye conditions like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy who recently received treatment. Researchers will measure changes in eye pressure, vision, and other outcomes over time. The goal is to understand how well current interventions work in real-world settings, beyond controlled clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Chronic Disease Intervention (CDI)
- What this could lead to
- If successful, this study could provide real-world evidence on how well current treatments work for chronic eye diseases like glaucoma and AMD over time.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by patient differences and cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Interstat
White Plains, New York, 10602, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new eye test match the gold standard for glaucoma?
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Which laser best tames glaucoma pressure?